Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
Home Page for TheBody.com, the Complete HIV/AIDS Resource What's New About HIV Ask the Experts About HIV HIV/AIDS Blogs Connect With Others About HIV Just Diagnosed With HIV HIV Treatment HIV Prevention Living With HIV Personal Stories of People With HIV
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

News Briefs

Uganda: More Pregnant Women Taking AIDS Drug

From U.S. Centers for Disease Control and Prevention

June 19, 2003

The number of pregnant Ugandan women taking nevirapine, the drug that helps prevent mothers from passing HIV to their newborns, is rapidly increasing -- an indication that more expectant mothers are gathering the courage to be tested for HIV. The Ministry of Health's 2002 report shows that 4,175 women received the drug, up from 3,929 in 2001. The number of pregnant women willing to undergo HIV tests grew from 46,993 in 2001 to 76,197 last year. "The Ministry of Health in 2002 developed a plan to increase the intervention to cover at least half of the country by 2002 and to establish at least one implementing site in all districts by the end of 2004," said Dr. Saul Onyango, coordinator of Prevention of Mother-to-Child Transmission of HIV. The 22 health centers currently dispensing nevirapine represent a fivefold increase from 2001.

Back to other CDC news for June 19, 2003

Previous Updates

Adapted from:
allAfrica.com
06.16.03; East African (Nairobi)

  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More on Women and HIV/AIDS in Africa

 

Advertisement